In short. Thin and highly mobile skin is where lumps and visible material are most likely. Where this substance should not be offered, and what answers those areas instead.

Key points

  • If material were placed here and did not sit perfectly evenly, would it be seen or only felt?
  • Areas where the answer is seen should be treated with a reversible option, where the result can be adjusted in both directions.
  • That single question does most of the work.

Most of this site describes how to decide whether this substance suits a person. This guide is about where it suits the face at all, because areas differ in ways that matter more than the individual patient does. The deciding factor is the tissue over the material: how thick it is, how much it moves, and how visible anything firm would be.

What makes an area unsuitable

Three properties, and they usually arrive together. Thin covering tissue, so that anything firm sits close to the surface where it can be seen rather than felt. Constant movement, which works against even integration and makes the tissue respond less predictably. And a low tolerance for irregularity, because an area that is looked at closely and often will show an unevenness that would pass unnoticed elsewhere. The lips, the surface of the eyelid and the fine skin around the mouth have all three to varying degrees.

The consequence is not a rule about specific zones but a principle that applies everywhere: the thinner and more mobile the covering tissue, the smaller the margin between a good result and a visible one.

Areas where this substance is reasonable

Areas with thicker covering tissue and less movement, where diffuse volume loss or a decline in tissue quality is the concern rather than a defined hollow. The temporal region and the midface are the usual examples. These are also areas where a gradual build suits the problem, because what is being restored is a broad loss rather than a single point.

The question that sorts an area

If material were placed here and did not sit perfectly evenly, would it be seen or only felt? Areas where the answer is seen should be treated with a reversible option, where the result can be adjusted in both directions. That single question does most of the work.

What the alternatives are

For a thin-skinned area that genuinely needs volume, a hyaluronic-acid filler is usually the honest answer: it is precise, its position can be judged immediately, and it can be dissolved if the result is not right. For a concern that is texture, pigment or surface quality rather than volume, the answer is not an injectable at all. For a defined hollow in a difficult area, a filler placed by someone experienced in that zone is a better instrument than a diffuse material.

Places not to accept a course

  • Lips or the fine skin around the mouth, where a firm area would be visible rather than merely palpable.
  • The surface of the eyelid or any area where the covering tissue is thin enough to show what is beneath it.
  • Any area where the plan is to place material close to the surface because the correction is wanted there.

A patient offered a course in one of these areas has learned something worth knowing about the practice, whatever its other merits. The judgement being asked for is not whether the result will be good, but whether the tissue gives any margin at all.

Related reading

Frequently asked questions

Why are the lips a poor area for this substance?

The covering tissue is thin, the area moves constantly and the material sits close to the surface. That combination makes a firm lump more likely to form and more likely to be visible rather than merely palpable. The lips are also an area where a reversible filler gives far more control.

What should be used for a thin-skinned area instead?

Usually a hyaluronic-acid filler, which is precise, immediate and can be dissolved. Where the concern is surface quality rather than volume, topical care and photoprotection address the problem at the level the skin actually has it.

Can a highly experienced injector treat these areas safely anyway?

Experience reduces the risk and does not remove it. The tissue that makes an area unsuitable does not change because the person injecting is skilled, and a plan that depends on technique overcoming anatomy is a plan with less margin than it appears to have.

Risks & Limitations

  • Irreversibility: there is no dissolving agent for this substance. A lump, an asymmetry or an over-correction is managed over time, with injected treatment, or occasionally by removal, and never switched off.
  • Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
  • Unevenness or over-correction. This substance is placed in an area that cannot be dissolved, so over-treatment is harder to correct than under-treatment.
  • Firmness under the skin in the first weeks, which is expected and usually settles, but does not always.
  • Infection or inflammation at an injection site, which needs prompt assessment rather than waiting.
  • Bruising, swelling, tenderness and occasional headache after treatment.
  • The volume visible on the day is the carrier rather than the effect. The result develops over months and cannot be judged early, it is not permanent, and the area continues to age.

When to Seek Care

  • A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
  • Redness, warmth, swelling or pus at an injection site, or fever.
  • Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
  • Increasing pain, or pain out of proportion to the injection.
  • Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.

References & Further Reading

  • American Academy of Dermatology (AAD) — injectable and skin safety information
  • American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
  • U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
  • National Medical Products Administration (NMPA, China) — approved product status
  • Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.